AAAAAA

   
Results: 1-25 | 26-27
Results: 1-25/27
INHIBITION OF ALLOREACTIVITY IN THE POPLITEAL LYMPH-NODE ASSAY BY MALONONITRILAMIDES
Authors: SCHORLEMMER HU BARTLETT RR KURRLE R
Citation: Hu. Schorlemmer et al., INHIBITION OF ALLOREACTIVITY IN THE POPLITEAL LYMPH-NODE ASSAY BY MALONONITRILAMIDES, Transplantation proceedings, 30(4), 1998, pp. 968-970
MALONONITRILAMIDES (MNA-279 AND MNA-715) HAVE THERAPEUTIC ACTIVITY INACUTE AND CHRONIC RELAPSING EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS (EAE)
Authors: SCHORLEMMER HU BARTLETT RR
Citation: Hu. Schorlemmer et Rr. Bartlett, MALONONITRILAMIDES (MNA-279 AND MNA-715) HAVE THERAPEUTIC ACTIVITY INACUTE AND CHRONIC RELAPSING EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS (EAE), Inflammation research, 46, 1997, pp. 163-164
VARIOUS GRAFT-VS-HOST DISEASES (GVHD) IN RODENTS CAN BE PREVENTED ANDTREATED BY MALONONITRILAMIDES (MNAS)
Authors: SCHORLEMMER HU KURRLE R BARTLETT RR
Citation: Hu. Schorlemmer et al., VARIOUS GRAFT-VS-HOST DISEASES (GVHD) IN RODENTS CAN BE PREVENTED ANDTREATED BY MALONONITRILAMIDES (MNAS), Inflammation research, 46, 1997, pp. 165-166
PREVENTION OF THE DEVELOPMENT OF MURINE SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE)-LIKE DISEASES BY THE MALONONITRILAMIDES MNA-279 AND MNA-715
Authors: SCHORLEMMER HU BARTLETT RR
Citation: Hu. Schorlemmer et Rr. Bartlett, PREVENTION OF THE DEVELOPMENT OF MURINE SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE)-LIKE DISEASES BY THE MALONONITRILAMIDES MNA-279 AND MNA-715, Inflammation research, 46, 1997, pp. 167-168
THE NEW IMMUNOSUPPRESSANTS, THE MALONONITRILAMIDES MNA-279 AND MNA-715, INHIBIT VARIOUS GRAFT-VS.-HOST DISEASES (GVHD) IN RODENTS
Authors: SCHORLEMMER HU KURRLE R BARTLETT RR
Citation: Hu. Schorlemmer et al., THE NEW IMMUNOSUPPRESSANTS, THE MALONONITRILAMIDES MNA-279 AND MNA-715, INHIBIT VARIOUS GRAFT-VS.-HOST DISEASES (GVHD) IN RODENTS, Drugs under experimental and clinical research, 23(5-6), 1997, pp. 167-173
THERAPEUTIC ACTIVITY OF MALONONITRILAMIDES (MNA-279 AND MNA-715) ON ACUTE AND CHRONIC, RELAPSING, EXPERIMENTAL, ALLERGIC ENCEPHALOMYELITIS (EAE)
Authors: SCHORLEMMER HU BARTLETT RR
Citation: Hu. Schorlemmer et Rr. Bartlett, THERAPEUTIC ACTIVITY OF MALONONITRILAMIDES (MNA-279 AND MNA-715) ON ACUTE AND CHRONIC, RELAPSING, EXPERIMENTAL, ALLERGIC ENCEPHALOMYELITIS (EAE), Drugs under experimental and clinical research, 23(5-6), 1997, pp. 175-181
EFFECTS OF THE IMMUNOSUPPRESSIVE MALONONITRILAMIDES ON RHEUMATOID ANDSYSTEMIC LUPUS-ERYTHEMATOSUS (SLE)-LIKE DISEASES
Authors: SCHORLEMMER HU BARTLETT RR
Citation: Hu. Schorlemmer et Rr. Bartlett, EFFECTS OF THE IMMUNOSUPPRESSIVE MALONONITRILAMIDES ON RHEUMATOID ANDSYSTEMIC LUPUS-ERYTHEMATOSUS (SLE)-LIKE DISEASES, International journal of immunotherapy, 13(1-2), 1997, pp. 1-7
ANALOGS OF LEFLUNOMIDES PRIMARY METABOLITE, THE MALONONITRILAMIDES, PREVENT THE DEVELOPMENT OF GRAFT-VERSUS-HOST DISEASE
Authors: SCHORLEMMER HU BARTLETT RR KURRLE R
Citation: Hu. Schorlemmer et al., ANALOGS OF LEFLUNOMIDES PRIMARY METABOLITE, THE MALONONITRILAMIDES, PREVENT THE DEVELOPMENT OF GRAFT-VERSUS-HOST DISEASE, Transplantation proceedings, 29(1-2), 1997, pp. 1298-1301
LEFLUNOMIDE, A NOVEL IMMUNOMODULATING DRUG, INHIBITS HOMOTYPIC ADHESION OF PERIPHERAL-BLOOD AND SYNOVIAL-FLUID MONONUCLEAR-CELLS IN RHEUMATOID-ARTHRITIS
Authors: DIMITRIJEVIC M BARTLETT RR
Citation: M. Dimitrijevic et Rr. Bartlett, LEFLUNOMIDE, A NOVEL IMMUNOMODULATING DRUG, INHIBITS HOMOTYPIC ADHESION OF PERIPHERAL-BLOOD AND SYNOVIAL-FLUID MONONUCLEAR-CELLS IN RHEUMATOID-ARTHRITIS, Inflammation research, 45(11), 1996, pp. 550-556
MALONONITRILAMIDES PREVENT THE DEVELOPMENT OF MURINE SYSTEMIC LUPUS ERYTHEMATOSUS-LIKE DISEASES IN BDF1 HYBRID MICE AND MRL LPR AUTOIMMUNE MICE/
Authors: SCHORLEMMER HU BRENDEL S BARTLETT RR
Citation: Hu. Schorlemmer et al., MALONONITRILAMIDES PREVENT THE DEVELOPMENT OF MURINE SYSTEMIC LUPUS ERYTHEMATOSUS-LIKE DISEASES IN BDF1 HYBRID MICE AND MRL LPR AUTOIMMUNE MICE/, Transplantation proceedings, 28(6), 1996, pp. 3040-3042
MALONONITRILAMIDES INHIBIT THE DEVELOPMENT OF VARIOUS MURINE GRAFT-VS-HOST DISEASES
Authors: SCHORLEMMER HU KURRLE R BARTLETT RR
Citation: Hu. Schorlemmer et al., MALONONITRILAMIDES INHIBIT THE DEVELOPMENT OF VARIOUS MURINE GRAFT-VS-HOST DISEASES, Transplantation proceedings, 28(6), 1996, pp. 3043-3047
A NOVEL IMMUNOMODULATING AGENT - LEFLUNOMIDE INHIBITS EXPERIMENTAL AUTOIMMUNE DIABETES IN MICE
Authors: STOSICGRUJICIC S DIMITRIJEVIC M BARTLETT RR
Citation: S. Stosicgrujicic et al., A NOVEL IMMUNOMODULATING AGENT - LEFLUNOMIDE INHIBITS EXPERIMENTAL AUTOIMMUNE DIABETES IN MICE, Transplantation proceedings, 28(6), 1996, pp. 3072-3073
LEFLUNOMIDE, AN IMMUNORESTORING DRUG FOR THE THERAPY OF AUTOIMMUNE DISORDERS, ESPECIALLY RHEUMATOID-ARTHRITIS
Authors: BARTLETT RR BRENDEL S ZIELINSKI T SCHORLEMMER HU
Citation: Rr. Bartlett et al., LEFLUNOMIDE, AN IMMUNORESTORING DRUG FOR THE THERAPY OF AUTOIMMUNE DISORDERS, ESPECIALLY RHEUMATOID-ARTHRITIS, Transplantation proceedings, 28(6), 1996, pp. 3074-3078
LEFLUNOMIDE, A NOVEL IMMUNOMODULATING DRUG, INHIBITS HOMOTYPIC ADHESION OF MONONUCLEAR-CELLS IN RHEUMATOID-ARTHRITIS
Authors: DIMITRIJEVIC M BARTLETT RR
Citation: M. Dimitrijevic et Rr. Bartlett, LEFLUNOMIDE, A NOVEL IMMUNOMODULATING DRUG, INHIBITS HOMOTYPIC ADHESION OF MONONUCLEAR-CELLS IN RHEUMATOID-ARTHRITIS, Transplantation proceedings, 28(6), 1996, pp. 3086-3087
THE INFLUENCE OF LEFLUNOMIDE ON CELL-CYCLE, IL-2-RECEPTOR (IL-2-R) AND ITS GENE-EXPRESSION (VOL 41, PG 204, 1994)
Authors: ZIELINSKI T HERMANN M MULLER HJ RIEDEL N BARTLETT RR
Citation: T. Zielinski et al., THE INFLUENCE OF LEFLUNOMIDE ON CELL-CYCLE, IL-2-RECEPTOR (IL-2-R) AND ITS GENE-EXPRESSION (VOL 41, PG 204, 1994), Inflammation research, 44(3), 1995, pp. 143-143
THE EFFECT OF A NOVEL COMPOUND HWA-486 METABOLITE A771726 ON PROLIFERATION OF SPLEEN COLONY-FORMING CELLS
Authors: MILENKOVIC P IVANOVIC Z DIMITRIJEVIC M BARTLETT RR
Citation: P. Milenkovic et al., THE EFFECT OF A NOVEL COMPOUND HWA-486 METABOLITE A771726 ON PROLIFERATION OF SPLEEN COLONY-FORMING CELLS, Experimental hematology, 23(8), 1995, pp. 775-775
LEFLUNOMIDE PREVENTS THE DEVELOPMENT OF EXPERIMENTALLY-INDUCED MYASTHENIA-GRAVIS
Authors: VIDICDANKOVIC B KOSEC D DAMJANOVIC M APOSTOLSKI S ISAKOVIC K BARTLETT RR
Citation: B. Vidicdankovic et al., LEFLUNOMIDE PREVENTS THE DEVELOPMENT OF EXPERIMENTALLY-INDUCED MYASTHENIA-GRAVIS, International journal of immunopharmacology, 17(4), 1995, pp. 273-281
PREVENTION OF THE ACUTE GRAFT-VERSUS-HOST DISEASE (GVHD) IN RATS BY THE IMMUNOMODULATING DRUG LEFLUNOMIDE
Authors: MROWKA C THOENES GH LANGER KH BARTLETT RR
Citation: C. Mrowka et al., PREVENTION OF THE ACUTE GRAFT-VERSUS-HOST DISEASE (GVHD) IN RATS BY THE IMMUNOMODULATING DRUG LEFLUNOMIDE, Annals of hematology, 68(4), 1994, pp. 195-199
LEFLUNOMIDE THERAPY FOLLOWING PENETRATING KERATOPLASTY IN THE RAT
Authors: COUPLAND SE KLEBE S KAROW AC KRAUSE L KRUSE H BARTLETT RR HOFFMANN F
Citation: Se. Coupland et al., LEFLUNOMIDE THERAPY FOLLOWING PENETRATING KERATOPLASTY IN THE RAT, Graefe's archive for clinical and experimental ophthalmology, 232(10), 1994, pp. 622-627
LEFLUNOMIDE (HWA-486) IN THE ALLOGENIC RAT PENETRATING KERATOPLASTY MODEL
Authors: COUPLAND SE KIEBE S KAROW AC KRAUSE L BARTLETT RR HOFFMANN F
Citation: Se. Coupland et al., LEFLUNOMIDE (HWA-486) IN THE ALLOGENIC RAT PENETRATING KERATOPLASTY MODEL, Investigative ophthalmology & visual science, 35(4), 1994, pp. 1878-1878
THE INFLUENCE OF LEFLUNOMIDE ON CELL-CYCLE, IL-2-RECEPTOR (IL-2-R) AND ITS GENE-EXPRESSION
Authors: ZIELINSKI T HERRMANN M MULLER HJ RIEDEL N BARTLETT RR
Citation: T. Zielinski et al., THE INFLUENCE OF LEFLUNOMIDE ON CELL-CYCLE, IL-2-RECEPTOR (IL-2-R) AND ITS GENE-EXPRESSION, Agents and actions, 41, 1994, pp. 30000204-30000205
SUPPRESSION OF AUTOIMMUNE RESPONSES AND INFLAMMATORY EVENTS BY LEFLUNOMIDE IN AN ANIMAL-MODEL FOR RHEUMATOID-ARTHRITIS
Authors: GLANT TT MIKECZ K BRENNAN F NEGROIU G BARTLETT RR
Citation: Tt. Glant et al., SUPPRESSION OF AUTOIMMUNE RESPONSES AND INFLAMMATORY EVENTS BY LEFLUNOMIDE IN AN ANIMAL-MODEL FOR RHEUMATOID-ARTHRITIS, Agents and actions, 41, 1994, pp. 30000267-30000270
THERAPEUTIC ACTIVITY OF LEFLUNOMIDE IN ACUTE AND CHRONIC RELAPSING EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS
Authors: SCHORLEMMER HU BARTLETT RR
Citation: Hu. Schorlemmer et Rr. Bartlett, THERAPEUTIC ACTIVITY OF LEFLUNOMIDE IN ACUTE AND CHRONIC RELAPSING EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS, Agents and actions, 41, 1994, pp. 30000271-30000273
DIFFERENTIAL-EFFECTS OF LEFLUNOMIDE ON LEUKOCYTES - INHIBITION OF RATIN-VIVO ADHESION AND HUMAN IN-VITRO OXIDATIVE BURST WITHOUT AFFECTINGSURFACE MARKER MODULATION
Authors: ZIELINSKI T MULLER HJ SCHLEYERBACH R BARTLETT RR
Citation: T. Zielinski et al., DIFFERENTIAL-EFFECTS OF LEFLUNOMIDE ON LEUKOCYTES - INHIBITION OF RATIN-VIVO ADHESION AND HUMAN IN-VITRO OXIDATIVE BURST WITHOUT AFFECTINGSURFACE MARKER MODULATION, Agents and actions, 41, 1994, pp. 30000276-30000278
EFFECTS OF LEFLUNOMIDE ON IMMUNE-RESPONSES AND MODELS OF INFLAMMATION
Authors: BARTLETT RR ANAGNOSTOPULOS H ZIELINSKI T MATTAR T SCHLEYERBACH R
Citation: Rr. Bartlett et al., EFFECTS OF LEFLUNOMIDE ON IMMUNE-RESPONSES AND MODELS OF INFLAMMATION, Perspectives in mathematical logic, 14(4), 1993, pp. 381-394
Risultati: 1-25 | 26-27